Methadone is a proven and effective medication for treating opioid use disorder as part of a medication-assisted treatment program. It can reduce opioid cravings, prevent withdrawal symptoms, and provide the stability some people need to focus on recovery.
However, methadone treatment does carry some risks, and methadone withdrawal is a possibility if the medication is stopped or reduced. Because methadone is a long-acting opioid, withdrawal can develop differently than it does with heroin, fentanyl, or many prescription opioids. Symptoms often begin later and may last longer.
Understanding why withdrawal occurs, what symptoms may feel like, and how long they can continue can help you make safer decisions about changing or stopping methadone.
Methadone withdrawal is the group of physical and psychological symptoms that can occur when someone who has become physically dependent on methadone suddenly stops taking it or reduces the dose too quickly.
Methadone works by acting on opioid receptors in the brain and nervous system. When the medication is taken regularly, the body gradually adjusts to its presence. Over time, the nervous system begins functioning with methadone as part of its normal environment.
If the medication is removed suddenly, the body needs time to adjust again. Withdrawal symptoms are part of that adjustment.
How uncomfortable withdrawal becomes can vary significantly from one person to another. Some people experience relatively mild symptoms during a carefully managed taper. Others may experience more intense physical symptoms, sleep problems, anxiety, or cravings.
Physical dependence and addiction are related concepts, but they are not the same thing.
Someone taking methadone exactly as prescribed can become physically dependent on the medication without being addicted to it.
This distinction is especially important for people receiving methadone for opioid use disorder. Developing physical dependence does not mean the treatment has failed. It is a biological effect that can occur with long-term use of several types of medications.
Methadone withdrawal can affect both physical and emotional health. Many symptoms resemble withdrawal from other opioids, although their onset and duration may differ.
Common symptoms may include:
Symptoms do not always appear at the same time. Withdrawal often develops gradually, with early symptoms such as restlessness, sweating, and sleep problems appearing before more noticeable muscle aches or digestive symptoms.
Some emotional symptoms can also continue after the strongest physical symptoms have improved.
There is no exact methadone withdrawal timeline that applies to everyone. Dose, length of use, metabolism, health, and whether methadone was stopped suddenly or gradually can all affect the experience.
Still, withdrawal often follows a general pattern.
Because methadone is long-acting, withdrawal may not begin immediately after the last dose.
Early symptoms can include anxiety, restlessness, yawning, sweating, watery eyes, runny nose, chills, and difficulty sleeping.
Symptoms may initially feel mild, particularly compared with withdrawal from shorter-acting opioids.
Symptoms may become more noticeable as the amount of methadone in the body continues to decrease.
During this period, a person may experience:
For some people, the most uncomfortable symptoms occur within the first several days.
Physical symptoms may begin to improve, but they usually do not disappear all at once.
Digestive symptoms and muscle aches may ease while fatigue, poor sleep, anxiety, and cravings continue.
The timeline can be longer for people who have taken methadone regularly for an extended period or who stop from a higher dose.
Some people continue to experience lingering symptoms after the more obvious physical withdrawal has passed.
These can include sleep disturbances, low energy, anxiety, low mood, difficulty concentrating, and cravings.
Recovery from withdrawal is not always a straight line. Someone may feel better for several days and then have another period of poor sleep or increased cravings. This does not necessarily mean something is wrong. The nervous system may simply need more time to adjust.
Methadone has a long half-life, which means it remains in the body much longer than many other opioids.
That characteristic is useful in opioid use disorder treatment. A properly managed dose can provide longer-lasting relief from opioid cravings and withdrawal without the rapid rise and fall associated with shorter-acting opioids.
But the same property affects withdrawal.
Heroin and some prescription opioids leave the body relatively quickly, so withdrawal may begin within hours. Methadone levels decrease more gradually. Withdrawal may therefore take longer to begin and continue for a longer period.
This slower process is one reason stopping methadone suddenly can be especially difficult.
Two people taking methadone may have very different withdrawal experiences.
Several factors can influence the severity and duration of symptoms:
These differences are also why copying someone else’s taper schedule is not a reliable way to stop methadone.
Methadone withdrawal is generally not associated with the same risk of life-threatening complications seen with severe alcohol or benzodiazepine withdrawal. Still, withdrawal can create meaningful health and safety concerns.
Persistent vomiting and diarrhea can cause dehydration and electrolyte problems. Severe insomnia, anxiety, depression, or cravings can also become difficult to manage without support.
One of the most serious concerns occurs after opioid tolerance decreases.
A person who has stopped or significantly reduced methadone may no longer tolerate the amount of opioids they previously used. Returning to fentanyl, heroin, prescription opioids, or a previous methadone dose can therefore increase the risk of overdose.
That is why getting through the physical symptoms is only one part of managing withdrawal safely. A plan should also consider cravings, mental health, relapse risk, and continued recovery support.
When someone wants or needs to stop methadone, clinicians commonly reduce the dose gradually instead of stopping it suddenly.
This process is known as tapering.
A gradual taper gives the nervous system more time to adjust as methadone levels decrease. It can make withdrawal symptoms more manageable and allows clinicians to monitor how the person responds.
There is no single taper schedule that works for everyone.
A taper may be influenced by:
A taper also does not always need to proceed at the same speed. A healthcare professional may slow or pause the process if withdrawal symptoms become difficult to manage.
Someone considering a taper should talk with the healthcare professional managing their methadone rather than changing the dose independently.
No. Successful methadone treatment does not require eventually becoming medication-free.
Some people use methadone for a shorter period and eventually decide to taper with medical guidance. Others benefit from longer-term maintenance.
The appropriate length of treatment depends on the individual.
If methadone is helping control cravings, prevent illicit opioid use, and create greater stability, remaining on the medication may continue to support recovery. There is no single point at which every person should stop.
The decision to taper should be based on health, stability, individual goals, and clinical guidance rather than pressure to prove that recovery is “complete.”
When to Seek Medical Help During Methadone Withdrawal
Medical attention may be especially important if withdrawal involves:
Professional support can also help if withdrawal symptoms simply become too difficult to manage alone.
If methadone withdrawal has become part of a larger struggle with opioids or other substances, professional care can provide more than symptom management.
Greylock Recovery in Williamstown, Massachusetts offers medically supervised detox with 24-hour monitoring, along with residential addiction treatment for people who need continued structure and clinical support. Treatment can also address mental health concerns, cravings, relapse risks, and other issues that may affect recovery.
Methadone can be an important and effective part of opioid use disorder treatment. Experiencing physical dependence or worrying about withdrawal does not change that. What matters is making medication decisions safely and with a plan that protects the progress you have made.
Call (413) 269-8387 or reach out online to learn more.
Jody Kocsis is a dependable team member dedicated to maintaining a safe, clean, and efficient facility environment. With a strong attention to detail and a commitment to quality, Jody supports daily operations and ensures a positive experience for all.
Eric Simmons is the Director of Case Management at Greylock Recovery, bringing more than 15 years of experience in behavioral health, substance use disorder treatment, residential programming, admissions, and case management. He has led program operations, patient advocacy initiatives, staff development, and outcome improvement efforts across residential and human service settings.
Prior to Greylock Recovery, Eric served as Director of Residential and Admissions Services for a local Berkshire county recovery facility, overseeing residential operations, admissions, referral development, and regulatory compliance. His expertise includes case management, discharge planning, community resource development, compliance, and staff training.
Eric earned a Bachelor of Arts in Sociology from Westfield State University, graduating Magna Cum Laude. He is committed to helping individuals overcome barriers to recovery and achieve lasting stability, while also serving his community as a youth football coach and mentor.
Jennifer Parsons is a seasoned human resources executive with more than 15 years of experience leading strategic HR initiatives, talent management, employee relations, and organizational development. Most recently, she served as Senior Vice President of Human Resources at Pittsfield Cooperative Bank, where she played a key role in fostering a positive workplace culture and supporting the organization’s growth and success.
Jennifer holds the Senior Professional in Human Resources (SPHR) certification from the Human Resource Certification Institute (HRCI), demonstrating her expertise and commitment to excellence in the HR profession. She also earned an associate’s degree in both Business Administration and Hospitality Administration, providing a strong foundation in leadership, operations, and customer service.
A Berkshire County native, Jennifer is deeply committed to her community and currently resides in the region with her family. In addition to her professional accomplishments, she serves on the Board of Directors for the Gladys Allen Brigham Center in Pittsfield, supporting the organization’s mission to empower women and strengthen the Community.
Jennifer Walker has been caring for others since 1989, starting out as a nurse’s aide and working her way through roles as a medical assistant, LPN, and RN. Along the way, she earned an associate’s degree in business administration and gathered an impressive range of experience—from primary care and long-term care to neurosurgery, neurology, colorectal surgery, orthopedics, and hospital-based surgical services. She’s also spent seven years helping individuals overcome substance use disorders, including time as a Director of Nursing, and has worked in hospice and with patients with disabilities.
But Jennifer’s dedication to people goes far beyond the workplace. A former foster parent and active supporter of local charities, she pours her heart into her community. When she’s not in scrubs, you can find her cheering at a sports game, tending to her garden, or enjoying laughter-filled moments with her family. Her blend of skill, heart, and positivity makes her not just a caregiver, but a true bright light for everyone she meets.
Elizabeth Azzariti, LICSW, is a seasoned clinical leader with over 10 years of experience in treating behavioral and addiction issues. After a successful 25-year career in the insurance industry, where she advanced to VP of Finance and Administration, she returned to school, earned her Master of Social Work from Wheelock College, and launched a new career dedicated to behavioral health. In her new role as Clinical Director at Greylock Recovery, she brings deep expertise in clinical operations, program development, and multidisciplinary team leadership. Most recently, as Executive Director at Nulife Behavioral Health, she served as both Clinical and Executive Director, leading the launch of PHP, IOP, TMS, Alumni, and Family programs while overseeing clinical staff hiring, supervision, and operations. She designed and implemented a 16-week evidence-based curriculum for co-occurring disorders that boosted attendance, retention, and patient outcomes. Her prior leadership roles include Clinical Supervisor at Blue Hills Recovery—directing multidisciplinary teams across PHP, IOP, and 24/7 residential programs—and at New England Recovery Center. EMDR-trained and specializing in trauma-informed care and integrated treatment, Elizabeth is passionate about delivering high-quality clinical care that supports lasting recovery for individuals and families.
Flora Sadri-Azarbayejani’s journey in the field of healthcare began at Boston University, where she earned her undergraduate degree in biomedical engineering.
Dr. Sadri-Azarbayejani pursued dual master’s degrees at Boston University, specializing in epidemiology and biostatistics, and medical science. She then attained her doctorate in medicine from the University of New England College of Osteopathic Medicine. Dr. Sadri-Azarbayejani’s professional career commenced as an epidemiologist in infectious disease at the Massachusetts Department of Public Health.
Eventually appointed as the Chief Medical Officer.She became board certified in addiction medicine and worked in the addiction space since 2014. She has worked both inpatient and outpatient addiction medicine. Opening programs in both arenas.
Currently serves as the medical director for substance use services at Lowell Community Health Center and for an inpatient addiction treatment center. Dr. Sadri-Azarbayejani is an active and engaged member of various medical societies, including the Massachusetts Medical Society, the American Academy of Family Physicians (AAFP), and the American Society of Addiction Medicine (ASAM).
Involved with development of CARF guidelines for outpatient addiction treatment programs. She also hopes to make an impact on passing legislation of supervised consumption sites in the near future.
Lauren Temple is a Licensed Clinical Social Worker (LICSW) bringing over 15 years of dedicated leadership in the behavioral health sector, with extensive expertise spanning inpatient, outpatient, and substance use disorder programming. She obtained her Master of Science in Social Administration from Case Western Reserve University and holds dual licensure as an LICSW in Massachusetts and an LISW-S in Ohio. Serving as the Executive Director for Greylock Recovery, Lauren manages clinical operations, regulatory adherence, and strategic growth to uphold the highest standards of patient-centric treatment.
Her professional background includes directing diverse clinical teams, broadening service accessibility, and overseeing quality improvement efforts while navigating complex accreditation and state regulatory cycles. Lauren remains deeply invested in cultivating elite clinical staff, improving recovery metrics, and championing evidence-based advancements in behavioral health care.